CD8A and neoplasm: They promote non-regulatory CD4 + and CD8 + T cell survival, maintain anti-apoptotic proteins BCL-XL, BCL-2 and BFL1 expression, increase cytokine production, enhance tumor-specific T cell immune responses, and increase tumor-specific memory T cell production after antigen challenge (Lee 2021).